The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist.
about
Perampanel for focal epilepsy: insights from early clinical experiencePerampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptabilityClinical efficacy of perampanel for partial-onset and primary generalized tonic-clonic seizuresPractice Update: Review of Anticonvulsant Therapy.The AMPA receptor antagonist perampanel in the adjunctive treatment of partial-onset seizures: clinical trial evidence and experience.Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis.Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizuresEpilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapyImpact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial-onset seizures: pooled analysis of clinical trials.Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokinetics.Perampanel for epilepsy with partial-onset seizures: a pharmacokinetic and pharmacodynamic evaluation.Perampanel: A Review in Drug-Resistant Epilepsy.Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs.Current role of perampanel in pediatric epilepsy.Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: A comparison of free non-protein-bound concentrations.Antiepileptic Drug Removal by Continuous Renal Replacement Therapy: A Review of the Literature.Structural Bases of Noncompetitive Inhibition of AMPA-Subtype Ionotropic Glutamate Receptors by Antiepileptic Drugs.Add-on perampanel in Lance-Adams syndrome.Perampanel, an AMPA receptor antagonist: From clinical research to practice in clinical settings.Add-on perampanel and aggressive behaviour in severe drug-resistant focal epilepsies.Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines.The Orally Active Noncompetitive AMPAR Antagonist Perampanel Attenuates Focal Cerebral Ischemia Injury in Rats.Adverse Events During Perampanel Adjunctive Therapy in Intractable Epilepsy.Simple and rapid validated HPLC-fluorescence determination of perampanel in the plasma of patients with epilepsy
P2860
Q26778392-9308FEBF-B974-4B6A-B6D1-107F1FEDE674Q26796447-232FD38F-0705-47F8-9EA7-3BC3E2D6566DQ28078666-024D4415-DB3A-4785-9B5B-0E172C9E9960Q34518509-689B491D-1E48-4AF8-8DD3-88183E5497D5Q35537344-A37EEEB8-99BA-49CF-AA67-5B8C765DB04EQ35761335-0C8773C5-2B34-4A3D-8A94-E510437619D9Q36554228-77489096-7FB3-49F5-97B4-A47C8B5CA263Q36893208-932219A9-1D3B-4B57-806E-2B68EAECD0D3Q37149455-01990CF9-60C9-46F5-B24C-794371C709E9Q38495389-2065E4CB-C876-406F-8E1C-CC098B7B6946Q38537865-795C94ED-3AB5-4E30-A757-BF563EE80353Q38586792-E682A715-360A-4499-8337-B27E972E0B20Q38599106-2C672E47-D4E5-425B-AF6A-81B8BC6244F5Q38617833-BAC7D608-45FB-49F9-BBCF-E606DD20E280Q38621010-96185145-36A3-4EF2-8D40-4822E12999FFQ38675314-AF2126C5-969E-4E14-A774-D5D971965992Q38764753-B97847A1-9701-4373-AAA4-28F452D5F947Q38944443-4AD8F351-10E5-433B-B585-9F81580E8866Q41159269-D11EFD92-6302-4204-A3A9-17388983F17BQ42426744-66B92695-FB0A-4CD1-8922-AA0EEA2B3A19Q48162513-4282C4FB-F928-4B85-B619-2DC2CB90B030Q49645049-7C7DD477-85F9-40C9-A685-EE34115A06BAQ50290626-9B16D897-C2D0-44BE-A146-6BD3D87BC1C3Q52098933-9A952E14-2248-4E8E-968B-B360917C59D8Q55452291-643804AD-CE68-46FF-8AA5-E0CD52EDE9F1Q56927827-A00FE55F-FED0-4142-B706-AB98A175C069
P2860
The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The clinical pharmacology prof ...... tive AMPA receptor antagonist.
@en
type
label
The clinical pharmacology prof ...... tive AMPA receptor antagonist.
@en
prefLabel
The clinical pharmacology prof ...... tive AMPA receptor antagonist.
@en
P2860
P356
P1433
P1476
The clinical pharmacology prof ...... tive AMPA receptor antagonist.
@en
P2093
Philip N Patsalos
P2860
P356
10.1111/EPI.12865
P577
2014-12-13T00:00:00Z